cancer pipeline – Talk Bio

Actionable Insights Powered by AI

BridgeBio Oncology Therapeutics Goes Public via $450M SPAC Merger

2 months ago talkbio0Tagged Biochemical Pathway, BridgeBio, cancer pipeline, Helix (Snails), inhibitors, K-ras Oncogene, KRAS, Merger, Neoplasms, PI3 K pathway, ras Oncogene, SPAC

BridgeBio, oncology, SPAC merger, Helix Acquisition Corp. II, KRAS inhibitors, cancer pipeline, RAS pathway, PI3K pathway

IDEAYA Advances Cancer Pipeline with Biocytogen’s Bispecific ADC, Targeting B7H3/PTK7

5 months ago talkbio0Tagged B7H3/PTK7, Biocytogen, bispecific ADC, cancer pipeline, IDEAYA, Precision Medicine, therapeutic autologous dendritic cells

IDEAYA, Biocytogen, Bispecific ADC, B7H3/PTK7, Cancer Pipeline, Precision Medicine Oncology

Incyte Discontinues Five Early-Stage Oncology Programs in Pipeline Refocus

9 months ago talkbio0Tagged cancer pipeline, Community Clinical Oncology Program, Incyte, inhibitors, PD-L1, R&D, strategic review

Incyte, cancer pipeline, oncology programs, PD-L1 inhibitors, strategic review, R&D refocus

ITM Secures €188 Million to Enhance Radiopharmaceutical Pipeline and Strengthen Medical Radioisotope Manufacturing

11 months ago talkbio0Tagged actinium-225, Authority, BlackRock, cancer pipeline, Gastro-enteropancreatic neuroendocrine tumor, Investments, Isotopes, medical radioisotopes, Munich, Qatar, Radiopharmaceuticals, SLC22A18 gene, Technology, Temasek

ITM Isotope Technologies Munich, radiopharmaceutical biotech, Temasek, BlackRock, Qatar Investment Authority, medical radioisotopes, Lutetium-177, Actinium-225, cancer pipeline, gastroenteropancreatic neuroendocrine tumors (GEP-NETs)